Relypsa, Inc. ( RLYP ) was a big mover last session with its shares rising over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above past one month's volatile price range of $22.61 to $24.98.
This pharmaceutical company has seen no estimate revision over the past 30 days. However, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Friday's rally can turn into more strength down the road.
Relypsa currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Medical Drug industry may consider better-ranked stocks like Akorn Inc. ( AKRX ), Mallinckrodt plc ( MNK ) and KaloBios Pharmaceuticals, Inc. ( KBIO ). While Akorn and Mallinckrodt sport a Zacks Rank #1 (Strong Buy), KaloBios bears a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportRELYPSA INC (RLYP): Free Stock Analysis ReportAKORN INC (AKRX): Free Stock Analysis ReportMALLINCKRODT PL (MNK): Free Stock Analysis ReportKALOBIOS PHARMA (KBIO): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research